90.66
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
11.97%
148.93
|
133.01 | 127.78 | 111.58 | 99.41 |
|
|
17.71%
153.50
|
130.41 | 132.77 | 126.77 | 123.64 |
| Benefits Costs and Expenses |
18.05%
153.90
|
130.37 | 133.24 | 125.23 | 123.78 |
| Costs And Expenses |
18.05%
153.90
|
130.37 | 133.24 | 125.23 | 123.78 |
| Operating Income/Loss |
275.45%
-4.567
|
2.603 | -4.989 | -15.18 | -24.22 |
| Income/Loss From Continuing Operations Before Tax |
287.78%
-4.963
|
2.643 | -5.459 | -13.65 | -24.37 |
| Income Tax Expense/Benefit |
392.75%
0.767
|
-0.262 | 0.402 | 1.029 | -0.576 |
| Income/Loss From Continuing Operations After Tax |
297.25%
-5.73
|
2.905 | -5.861 | -14.68 | -23.79 |
|
|
297.25%
-5.73
|
2.905 | -5.861 | -14.68 | -23.79 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.13%
0.4402
|
50.64 | 49.73 | 48.89 | 0.2058 |
| Diluted Average Shares |
99.23%
0.4402
|
56.99 | 49.73 | 48.89 | 0.2058 |
| Basic Earnings Per Share |
300.00%
-0.12
|
0.06 | -0.12 | -0.30 | -0.49 |
| Diluted Earnings Per Share |
340.00%
-0.12
|
0.05 | -0.12 | -0.30 | -0.49 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):